0000890465-14-000006.txt : 20140109
0000890465-14-000006.hdr.sgml : 20140109
20140109164908
ACCESSION NUMBER: 0000890465-14-000006
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140107
FILED AS OF DATE: 20140109
DATE AS OF CHANGE: 20140109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000890465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 870439579
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
BUSINESS PHONE: (908) 450-5300
MAIL ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rogus Joseph J
CENTRAL INDEX KEY: 0001299691
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23272
FILM NUMBER: 14519216
MAIL ADDRESS:
STREET 1: 550 HILLS DRIVE
STREET 2: 3RD FLOOR
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2014-01-07
0000890465
NPS PHARMACEUTICALS INC
NPSP
0001299691
Rogus Joseph J
550 HILLS DRIVE
BEDMINSTER
NJ
07921
0
1
0
0
VP, Technical Operations
Stock Options
3.34
2014-01-07
4
A
0
8625
0
A
2020-02-19
Common Stock
8625
112125
D
On February 19, 2010, the Reporting Person was granted options to purchase shares of Common Stock under the Issuer's 2005 Omnibus Incentive Plan, which are subject to both performance conditions and time-based vesting. On January 7, 2014, the performance criteria for 8,625 of these options was satisfied when the FDA accepted the BLA for Natpara for the treatment of hypoparathyroidism. As of January 7, 2014, the performance criteria and the time-based criteria for 71,156 of these options has been satisfied. These options will vest and become exercisable based on the following vesting schedule: 25% on each of the first four anniversaries of the date of grant.
/s/ Joseph Rogus, by Edward Stratemeier as attorney-in-fact
2014-01-09